Triamcinolone Shortage: What Providers and Prescribers Need to Know in 2026

Triamcinolone acetonide injectable suspension — the corticosteroid workhorse of rheumatology, orthopedics, dermatology, and allergy — has been in an active ASHP-tracked shortage since June 2025. As of early 2026, the shortage has not resolved and involves virtually every major generic manufacturer simultaneously. This briefing covers the current supply picture, therapeutic alternatives, prescribing implications, and practical strategies for managing affected patients.

Current Supply Status (As of Early 2026)

The following is the manufacturer-level status according to ASHP Drug Shortage Bulletins:

Viatris: 40 mg/mL (5 mL and 10 mL) on back order. Estimated release late June 2026.

Bristol-Myers Squibb (Kenalog-40): 1 mL, 5 mL, and 10 mL vials impacted. No reason given for brand shortage.

Amneal: On allocation to contracted customers — not broadly available on open market.

Hikma: 40 mg/mL 1 mL vials on allocation. No stated reason.

Long Grove: Intermittent back order; releasing product as available. Cites increased demand.

Eugia: Permanently discontinued in mid-2025. No longer an available source.

Teva: In shortage. No reason given.

Therapeutic Alternatives by Indication

Intra-articular and soft-tissue injections (OA, RA, bursitis, tendinitis):

Methylprednisolone acetate (Depo-Medrol) 40 mg/mL or 80 mg/mL: Most direct equivalent. Widely available. Note that crystal size is larger than triamcinolone and may increase short-term post-injection flare risk at some sites.

Betamethasone acetate/phosphate (Celestone Soluspan) 6 mg/mL: Longer-acting, lower flare risk due to smaller crystal size. Consider for large joint injections. Note: shorter supply chain for retail patients.

Zilretta (triamcinolone acetonide extended-release) 32 mg: For knee OA only; operates in a separate specialty supply chain. May be available when standard Kenalog vials are not.

Intralesional injections (keloids, acne cysts, alopecia areata):

Triamcinolone 10 mg/mL (Kenalog-10) may be separately available — check your distributor for 1 mL or 5 mL vials at 10 mg/mL; these may not be in the same tight supply as 40 mg/mL.

Diluting 40 mg/mL with preservative-free saline to achieve 10 mg/mL is a reasonable clinical workaround when product is otherwise unavailable — consult your pharmacist on sterile dilution protocols.

Intramuscular (systemic) injections (allergy, IM corticosteroid):

Dexamethasone 4-10 mg IM: Immediate availability for acute allergic reactions; shorter duration than triamcinolone IM.

Methylprednisolone succinate IV/IM: Available for acute systemic use; not a direct depot substitute.

Formulary and Practice Management Considerations

Practices that routinely stock triamcinolone for in-office injections should proactively communicate with their distributor about allocation eligibility. Hospital outpatient practices with formulary access through group purchasing organizations (GPOs) may find Amneal or Hikma product available through contracted channels even while retail pharmacies are dry.

For practices that dispense injections in-office, document the shortage and the alternative agent used in the patient record. This is important both clinically and for billing purposes if a substitution is made.

Patient Communication Strategies

Patients scheduled for triamcinolone injection procedures may arrive having already been told by their pharmacy that the medication is unavailable. Proactive communication from your practice is better than reactive. Consider:

Sending a pre-visit notice to patients scheduled for triamcinolone injection explaining that an equivalent corticosteroid may be substituted

Updating your practice's shortage protocol to include triamcinolone alongside other commonly shortage-affected medications

Directing patients who need to fill a take-home triamcinolone prescription to medfinder.com/providers, which can help locate stocked pharmacies

A Tool for Your Patients: medfinder for Providers

When patients need to fill a triamcinolone prescription at a retail pharmacy — including topical cream, nasal spray, or injectable formulations — medfinder for Providers enables your team to quickly identify stocked pharmacies near the patient. medfinder calls pharmacies on the patient's behalf, reducing patient burden and call volume to your office.

See our companion guide: How to Help Your Patients Find Triamcinolone in Stock: A Provider's Guide for a step-by-step workflow you can implement in your practice.